Physician
ST. Vincent Pathology Medical Group
ST. Vincent Pathology Medical Group was paid $1.41M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 31% of everything it billed.
33Billing provider infoST. VINCENT PATHOLOGY MEDICAL GROUP
LOS ANGELES, CA 90027
LOS ANGELES, CA 90027
33aNPI1689635773assigned 03/29/2006
33bProvider typeCytopathology Physician
28Total paid$1.41M
24GClaims512,243
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cytopathology Physician providers in California
Rank by total paid#10 of 69
Median peer was paid$50K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,537 | $75K | |
| 2019 | 29,732 | $79K | |
| 2020 | 76,672 | $166K | |
| 2021 | 122,191 | $282K | |
| 2022 | 94,126 | $291K | |
| 2023 | 98,904 | $348K | |
| 2024incomplete | 65,081 | $170K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 31% | 11,536 | 11,077 | $432K |
| 88307 | 12% | 3,429 | 3,365 | $171K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.4% | 82,956 | 42,522 | $90K |
| 80053 | Comprehensive metabolic panel | 6.3% | 59,248 | 33,294 | $89K |
| 88312 | 5.5% | 3,064 | 3,033 | $78K | |
| 88304 | 4.1% | 3,959 | 3,891 | $58K | |
| 88342 | 3.2% | 1,544 | 1,506 | $45K | |
| 82948 | 2.5% | 33,717 | 9,837 | $35K | |
| 83880 | 2.0% | 6,772 | 4,806 | $28K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 10,102 | 9,002 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.7% | 18,298 | 9,831 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 3,800 | 3,448 | $23K |
90 more codes
| 84484 | 1.5% | 14,541 | $21K | |
| 83735 | 1.3% | 19,252 | $18K | |
| 87040 | 1.1% | 6,647 | $15K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 1,444 | $15K |
| 85730 | <1% | 17,056 | $14K | |
| 85610 | <1% | 19,615 | $12K | |
| 80074 | <1% | 1,684 | $10K | |
| 83690 | <1% | 11,004 | $10K | |
| 81001 | <1% | 17,110 | $9K | |
| 83605 | <1% | 5,097 | $9K | |
| 85027 | <1% | 8,306 | $8K | |
| 86780 | <1% | 4,974 | $8K | |
| 88341 | <1% | 214 | $8K | |
| 82247 | <1% | 10,647 | $7K | |
| 86920 | <1% | 1,635 | $7K | |
| 82962 | <1% | 1,624 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,486 | $7K |
| 86906 | <1% | 9,665 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,774 | $7K |
| 87340 | <1% | 5,019 | $5K | |
| 80061 | Lipid panel | <1% | 3,344 | $5K |
| 86850 | <1% | 9,849 | $5K | |
| 87186 | <1% | 2,884 | $5K | |
| 82248 | <1% | 10,944 | $5K | |
| 84100 | <1% | 8,980 | $5K | |
| 86880 | <1% | 5,794 | $4K | |
| 87077 | <1% | 2,850 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,891 | $4K |
| 88302 | <1% | 219 | $4K | |
| 80069 | <1% | 3,163 | $4K | |
| 81025 | <1% | 3,082 | $3K | |
| 87081 | <1% | 3,599 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,617 | $3K |
| 84703 | <1% | 3,408 | $3K | |
| 80202 | <1% | 1,528 | $3K | |
| 82378 | <1% | 966 | $3K | |
| 86077 | <1% | 118 | $3K | |
| 85379 | <1% | 1,828 | $2K | |
| 87070 | <1% | 1,827 | $2K | |
| 82550 | <1% | 2,749 | $2K | |
| 86140 | <1% | 2,978 | $2K | |
| 84702 | <1% | 1,466 | $2K | |
| 82140 | <1% | 1,068 | $2K | |
| 85007 | <1% | 4,125 | $2K | |
| 82728 | <1% | 1,098 | $2K | |
| 86762 | <1% | 994 | $2K | |
| 83615 | <1% | 2,506 | $2K | |
| 85384 | <1% | 1,326 | $2K | |
| 87806 | <1% | 897 | $1K | |
| 83550 | <1% | 1,300 | $1K | |
| 82553 | <1% | 667 | $1K | |
| 87205 | <1% | 1,600 | $930.54 | |
| 82150 | <1% | 1,000 | $837.38 | |
| 87075 | <1% | 603 | $798.92 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 211 | $787.67 |
| 85018 | <1% | 2,663 | $719.20 | |
| 84145 | <1% | 299 | $676.76 | |
| 85014 | <1% | 2,272 | $637.06 | |
| 82607 | <1% | 329 | $569.11 | |
| 82746 | <1% | 321 | $552.47 | |
| 85651 | <1% | 1,460 | $512.23 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 63 | $494.00 |
| 84550 | <1% | 1,451 | $480.64 | |
| 87400 | <1% | 517 | $328.17 | |
| 85044 | <1% | 582 | $312.28 | |
| 82570 | <1% | 361 | $286.93 | |
| 88311 | <1% | 124 | $237.32 | |
| 88363 | <1% | 32 | $229.29 | |
| 80076 | <1% | 218 | $200.11 | |
| 84439 | <1% | 153 | $156.88 | |
| 85362 | <1% | 152 | $138.20 | |
| 84436 | <1% | 115 | $112.81 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 38 | $102.84 |
| 83970 | <1% | 29 | $102.38 | |
| 86870 | <1% | 38 | $102.29 | |
| 84153 | <1% | 30 | $93.59 | |
| 84156 | <1% | 202 | $89.51 | |
| 86901 | <1% | 274 | $88.10 | |
| 81003 | <1% | 214 | $85.71 | |
| 84478 | <1% | 143 | $66.82 | |
| 86900 | <1% | 288 | $61.88 | |
| 85347 | <1% | 29 | $25.73 | |
| 87147 | <1% | 30 | $22.10 | |
| 87101 | <1% | 19 | $20.79 | |
| 82105 | <1% | 13 | $20.01 | |
| 84300 | <1% | 19 | $14.39 | |
| 86431 | <1% | 25 | $14.16 | |
| 82977 | <1% | 13 | $10.38 | |
| 82565 | <1% | 17 | $5.91 | |
| 84157 | <1% | 12 | $4.44 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONRAD, LU (PRESIDENT)